{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T07:49:00Z","timestamp":1746085740000},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T00:00:00Z","timestamp":1366329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2334-13-182","type":"journal-article","created":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T10:17:10Z","timestamp":1366366630000},"source":"Crossref","is-referenced-by-count":11,"title":["Prognosis of patients with methicillin-resistant Staphylococcus aureusbloodstream infection treated with teicoplanin: a retrospective cohort study investigating effect of teicoplanin minimum inhibitory concentrations"],"prefix":"10.1186","volume":"13","author":[{"given":"Jann-Tay","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hau-Shin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Min","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le-Yin","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Der","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,19]]},"reference":[{"key":"2375_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.7326\/0003-4819-144-5-200603070-00005","volume":"144","author":"MD King","year":"2006","unstructured":"King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM: Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med. 2006, 144: 309-317. 10.7326\/0003-4819-144-5-200603070-00005.","journal-title":"Ann Intern Med"},{"key":"2375_CR2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1056\/NEJMoa055356","volume":"355","author":"GJ Moran","year":"2006","unstructured":"Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA: EMERGEncy ID group: Methicillin-resistant Staphylococcus aureus infections among patients in the emergency department. N Engl J Med. 2006, 355: 666-674. 10.1056\/NEJMoa055356.","journal-title":"N Engl J Med"},{"key":"2375_CR3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1086\/499815","volume":"42","author":"U Seybold","year":"2006","unstructured":"Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, King MD, Ray SM, Blumberg HM: Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infec Dis. 2006, 42: 647-656. 10.1086\/499815.","journal-title":"Clin Infec Dis"},{"key":"2375_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3201\/eid1302.060781","volume":"13","author":"CL Maree","year":"2007","unstructured":"Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG: Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis. 2007, 13: 236-242. 10.3201\/eid1302.060781.","journal-title":"Emerg Infect Dis"},{"key":"2375_CR5","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1128\/AAC.00939-06","volume":"51","author":"PA Moise","year":"2007","unstructured":"Moise PA, Sakoulas G, Forrest A, Schentag JJ: Vancomycin in vitro bacterial activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bloodstream infection. Antimicrob Agents Chemother. 2007, 51: 2582-2586. 10.1128\/AAC.00939-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"2375_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1086\/524667","volume":"46","author":"A Soriano","year":"2008","unstructured":"Soriano A, Marco F, Martinez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J: Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2008, 46: 193-200. 10.1086\/524667.","journal-title":"Clin Infect Dis"},{"key":"2375_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/jac\/dkl006","volume":"57","author":"CT Fang","year":"2006","unstructured":"Fang CT, Shau WY, Hsueh PR, Chen YC, Wang JT, Hung CC, Huang LY, Chang SC: Early empirical glycopeptides therapy for patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on the outcome. J Antimicrob Chemother. 2006, 57: 511-519. 10.1093\/jac\/dkl006.","journal-title":"J Antimicrob Chemother"},{"key":"2375_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jinf.2010.09.029","volume":"61","author":"JT Wang","year":"2010","unstructured":"Wang JT, Wang JL, Fang CT, Chie WC, Lai MS, Lauderdale TL, Weng CM, Chang SC: Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: with investigation of the potential role of community-associated MRSA strains. J Infect. 2010, 61: 449-457. 10.1016\/j.jinf.2010.09.029.","journal-title":"J Infect"},{"key":"2375_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/cid\/cir764","volume":"54","author":"CL Moore","year":"2012","unstructured":"Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ: Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case\u2013control study. Clin Infect Dis. 2012, 54: 51-58. 10.1093\/cid\/cir764.","journal-title":"Clin Infect Dis"},{"key":"2375_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2146\/ajhp080434","volume":"66","author":"M Rybak","year":"2009","unstructured":"Rybak M, Lomaestro B, Rotschafer JC, Moellering R, Craig W, Billeter M, Dalovisio JR, Levine DP: Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009, 66: 82-98. 10.2146\/ajhp080434.","journal-title":"Am J Health Syst Pharm"},{"key":"2375_CR11","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1128\/JCM.02135-08","volume":"47","author":"AC Musta","year":"2009","unstructured":"Musta AC, Riederer K, Shemes S, Chase P, Jose J, Johnson LB, Khatib R: Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years. J Clin Microbiol. 2009, 47: 1640-1644. 10.1128\/JCM.02135-08.","journal-title":"J Clin Microbiol"},{"key":"2375_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijantimicag.2007.03.015","volume":"30","author":"DJ Biedenbach","year":"2007","unstructured":"Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD: Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003\u20132004). Int J Antimicrob Agents. 2007, 30: 143-149. 10.1016\/j.ijantimicag.2007.03.015.","journal-title":"Int J Antimicrob Agents"},{"key":"2375_CR13","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1128\/AAC.01022-08","volume":"53","author":"MM Traczewski","year":"2009","unstructured":"Traczewski MM, Katz BD, Steenbergen JN, Brown SD: Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007. Antimicrob Agents Chemother. 2009, 53: 1735-1738. 10.1128\/AAC.01022-08.","journal-title":"Antimicrob Agents Chemother"},{"key":"2375_CR14","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/jac\/dkr531","volume":"67","author":"HJ Chang","year":"2012","unstructured":"Chang HJ, Hsu PC, Yang CC, Kiu LK, Kuo AJ, Chia JH, Wu TL, Huang CT, Lee MH: Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteremia: a hospital-based retrospective study. J Antimicrob Chemother. 2012, 67: 736-741. 10.1093\/jac\/dkr531.","journal-title":"J Antimicrob Chemother"},{"key":"2375_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA: CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008, 36: 309-332. 10.1016\/j.ajic.2008.03.002.","journal-title":"Am J Infect Control"},{"key":"2375_CR16","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest. 1992, 101: 1644-1655. 10.1378\/chest.101.6.1644.","journal-title":"Chest"},{"key":"2375_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40: 373-383. 10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"key":"2375_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.diagmicrobio.2007.04.024","volume":"59","author":"YC Tseng","year":"2007","unstructured":"Tseng YC, Wang JT, Wu FL, Chen YC, Chie WC, Chang SC: Prognosis of adult patients with bloodstream infection caused by extensively resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis. 2007, 59: 181-190. 10.1016\/j.diagmicrobio.2007.04.024.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2375_CR19","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1742-7843.2012.00862.x","volume":"110","author":"JT Wang","year":"2012","unstructured":"Wang JT, Liao HI, Wu Lin FL, Chang SC: Loading dose required to achieve rapid therapeutic teicoplanin trough plasma concentration in patients with multidrug-resistant gram-positive infections. Basic Clin Pharmacol Toxicol. 2012, 110: 416-420. 10.1111\/j.1742-7843.2012.00862.x.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2375_CR20","volume-title":"CLSI","author":"Clinical and Laboratory Standards Institute (CLSI","year":"2006","unstructured":"Clinical and Laboratory Standards Institute (CLSI: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. CLSI. 2006, Wayne, PA: CLSI document M7-A4, Seventh","edition":"Seventh"},{"key":"2375_CR21","volume-title":"CLSI","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008","unstructured":"Clinical and Laboratory Standards Institute (CLSI): Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement. CLSI. 2008, Wayne, PA: CLSI document M100\u2013S18"},{"key":"2375_CR22","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1128\/JCM.38.3.1008-1015.2000","volume":"38","author":"MC Enright","year":"2000","unstructured":"Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG: Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible Staphylococcus aureus. J Clin Microbiol. 2000, 38: 1008-1015.","journal-title":"J Clin Microbiol"},{"key":"2375_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/cir034","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak MJ, Talan DA, Chambers HF: Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011, 52: 1-38. 10.1093\/cid\/ciq015.","journal-title":"Clin Infect Dis"},{"key":"2375_CR24","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jmii.2011.01.037","volume":"44","author":"TM Kao","year":"2011","unstructured":"Kao TM, Wang JT, Weng CM, Chen YC, Chang SC: In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006\u20132008: stratified analysis by vancomycin MIC. J Microbiol Immunol Infect. 2011, 44: 346-351. 10.1016\/j.jmii.2011.01.037.","journal-title":"J Microbiol Immunol Infect"},{"key":"2375_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/jac\/dkr024","volume":"66","author":"JH Song","year":"2011","unstructured":"Song JH, Hsueh PR, Chung DR, Ko KS, Kang CI, Peck KR, Yeom JS, Kim SW, Chang HH, Kim YS: Spread of methicillin-resistant Staphylococcus aureus between the community and hospitals in Asian countries: an ANSORP study. J Antimicorb Chemother. 2011, 66: 1061-1069. 10.1093\/jac\/dkr024.","journal-title":"J Antimicorb Chemother"},{"key":"2375_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.diagmicrobio.2009.05.020","volume":"65","author":"CJ Chen","year":"2009","unstructured":"Chen CJ, Hsueh PR, Su LH, Chiu CH, Lin TY, Huang YC: Change in the molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream infections in Taiwan. Diagn Microbiol Infect Dis. 2009, 65: 199-201. 10.1016\/j.diagmicrobio.2009.05.020.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2375_CR27","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST): Breakpoint tables for interpretation of MICs and zone diameters. http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Disk_test_documents\/EUCAST_breakpoints_v1.1.xls ,"},{"key":"2375_CR28","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1128\/AAC.00269-10","volume":"54","author":"P Vaudaux","year":"2010","unstructured":"Vaudaux P, Huggler E, Bernard L, Ferry T, Renzoni A, Lew DP: Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus. Antimicrob Agents Chemother. 2010, 54: 3861-3870. 10.1128\/AAC.00269-10.","journal-title":"Antimicrob Agents Chemother"},{"key":"2375_CR29","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/jac\/45.6.835","volume":"45","author":"I Harding","year":"2000","unstructured":"Harding I, MacGownan AP, White LO, Darley ESR, Reed V: Teicoplanin therapy for Staphylococcus aureus bacteremia: relationship between pre-dose serum concentrations and outcome. J Antimicrob Chemother. 2000, 45: 835-841. 10.1093\/jac\/45.6.835.","journal-title":"J Antimicrob Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-182\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T17:04:48Z","timestamp":1595696688000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,19]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2375"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-182","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,19]]},"article-number":"182"}}